APP and Alzheimer disease: In recent years, several miRNAs have been identified to participate in AD pathogenesis by regulating the expression of multiple target genes, including APP. miR-106a and miR-520c were the first miRNAs experimentally demonstrated to downregulate APP levels post-transcriptionally (Patel et al., 2008).